Hikma Pharmaceuticals's total assets for Q2 2025 were $5.55B, an increase of 8.20% from the previous quarter. GB:HIK total liabilities were $3.00B for the fiscal quarter, a 6.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.